NCT06133114View on ClinicalTrials.gov

Psychopharmacological Treatment of Emotional Distress

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Suicide Crisis SyndromePsychological Distress
Interventions
DRUG

Clonazepam

0.5 mg twice a day (1 mg a day)

DRUG

Olanzapine

2.5 mg once a day of Olanzapine

DRUG

Buprenorphine

2 mg once a day of Buprenorphine

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER